• Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine 

      Watle, Sara Sofie Viksmoen; Næss, Lisbeth Meyer; Tunheim, Gro; Caugant, Dominique A; Wisløff, Torbjørn (Journal article; Tidsskriftartikkel; Peer reviewed, 2021-02-25)
      In Norway, the incidence of invasive meningococcal disease (IMD) is higher among 16–19-year-olds than in the general population. Most IMD cases among teenagers are caused by serogroup Y. Since 2011, one dose of meningococcal ACWY conjugate vaccine (MCV4) has been recommended for teenagers with out-of-pocket payment. The teenagers are usually vaccinated through the school health service at age 18. ...